Ibsrela

Ibsrela (tenapanor) is a prescription medication used to treat Irritable bowel syndrome with constipation (IBS-C). A twice-daily pill for adults with irritable bowel syndrome with constipation (IBS-C).

Blocks the NHE3 transporter in the gut, increasing fluid in the intestines to ease bowel movements and reduce pain.

Commonly reported side effects of Ibsrela include Diarrhea, Should not be used in young children (boxed warning), Gas, and Abdominal pain. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Ibsrela carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Ibsrela is tenapanor, which belongs to a class of medicines known as Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitor.

Ibsrela is manufactured by Ardelyx. It was first approved in 2019.

You may be able to lower the cost of Ibsrela by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.